These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 16634110

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vaccinia virus replication is independent of cellular HSP72 expression which is induced during virus infection.
    Sedger L, Ramshaw I, Condie A, Medveczky J, Braithwaite A, Ruby J.
    Virology; 1996 Nov 15; 225(2):423-7. PubMed ID: 8918931
    [Abstract] [Full Text] [Related]

  • 27. Construction and evaluation of live attenuated myxoma virus vaccines with targeted virulence gene deletions.
    Adams MM, van Leeuwen BH, Kerr PJ.
    Vaccine; 2008 Oct 29; 26(46):5843-54. PubMed ID: 18789367
    [Abstract] [Full Text] [Related]

  • 28. Skin inflammation in RelB(-/-) mice leads to defective immunity and impaired clearance of vaccinia virus.
    Freyschmidt EJ, Mathias CB, MacArthur DH, Laouar A, Narasimhaswamy M, Weih F, Oettgen HC.
    J Allergy Clin Immunol; 2007 Mar 29; 119(3):671-9. PubMed ID: 17336617
    [Abstract] [Full Text] [Related]

  • 29. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments In Vivo.
    de Freitas LFD, Oliveira RP, Miranda MCG, Rocha RP, Barbosa-Stancioli EF, Faria AMC, da Fonseca FG.
    J Virol; 2019 Mar 15; 93(6):. PubMed ID: 30567985
    [Abstract] [Full Text] [Related]

  • 30. The immune response to vaccinia virus is significantly reduced after scarification with TK- recombinants as compared to wild-type virus.
    Phillpotts RJ, Lescott T, Gates AJ, Jones L.
    Acta Virol; 2000 Mar 15; 44(3):151-6. PubMed ID: 11155357
    [Abstract] [Full Text] [Related]

  • 31. Vaccination of mice with replication-defective human immunodeficiency virus induces cellular and humoral immunity and protects against vaccinia virus-gag challenge.
    Baliga CS, van Maanen M, Chastain M, Sutton RE.
    Mol Ther; 2006 Sep 15; 14(3):432-41. PubMed ID: 16713742
    [Abstract] [Full Text] [Related]

  • 32. Complementation of a vaccinia virus host-range K1L gene deletion by the nonhomologous CP77 gene.
    Ramsey-Ewing AL, Moss B.
    Virology; 1996 Aug 01; 222(1):75-86. PubMed ID: 8806489
    [Abstract] [Full Text] [Related]

  • 33. Antigenic properties of vaccinia virus and of the virus recombinant strains expressing heterologous genes.
    Chelyapov NV, Antonova TP, Yanova NN, Chernos VI.
    Acta Virol; 1988 Sep 01; 32(5):409-16. PubMed ID: 2904735
    [Abstract] [Full Text] [Related]

  • 34. Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.
    Fang Q, Yang L, Zhu W, Liu L, Wang H, Yu W, Xiao G, Tien P, Zhang L, Chen Z.
    Virology; 2005 May 10; 335(2):242-51. PubMed ID: 15840523
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Vaccinia virus gene B7R encodes an 18-kDa protein that is resident in the endoplasmic reticulum and affects virus virulence.
    Price N, Tscharke DC, Hollinshead M, Smith GL.
    Virology; 2000 Feb 01; 267(1):65-79. PubMed ID: 10648184
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. In vivo delivery of interleukin-6 using vaccinia virus: effects on T lymphocytes in nude mice.
    Nakagawa N, Nakagawa T, Acres B, Yasukawa K, Kieny MP.
    Eur Cytokine Netw; 1991 Feb 01; 2(1):11-6. PubMed ID: 1873489
    [Abstract] [Full Text] [Related]

  • 39. [Expression of the gene for vaccinia virus 36K nonstructural protein in Escherichia coli and study of the protective properties of expression products].
    Iashina LN, Gileva IP, Ryzhikov AB, Poryvaeva VA, Riazankin IA, Bondar' TS, Ovechkina LG, Riazankina OI, Malygin EG.
    Mol Gen Mikrobiol Virusol; 1997 Feb 01; (3):36-40. PubMed ID: 9297111
    [Abstract] [Full Text] [Related]

  • 40. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT, Brühl P, Schmidt M, Wieser V, Gritschenberger W, Coulibaly S, Savidis-Dacho H, Gerencer M, Falkner FG.
    J Virol; 2002 Aug 01; 76(15):7713-23. PubMed ID: 12097585
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.